M. Battaglia
Immunology · Immunological Reviews · 2005–2011
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 97 citations into it; #1,198 of 2,160 by trust here, #1,025 by citations
- Oncology — 10 citations into it; #1,415 of 1,698 by trust here, #1,114 by citations
Whom M. Battaglia trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Battaglia overall
Papers from M. Battaglia's perspective
Ordered by how strongly the researchers M. Battaglia trusts endorse each paper. Same corpus, a different order for every researcher.
- Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. (Annual Review of Immunology)
- Multiple immuno-regulatory defects in type-1 diabetes. (Journal of Clinical Investigation)
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells (Journal of Experimental Medicine)
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis (Journal of Experimental Medicine)
- Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells (Journal of Experimental Medicine)
- Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells (Journal of Experimental Medicine)
- Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood (Journal of Experimental Medicine)
- CD4+CD25+ suppressor T cells: more questions than answers (Nature reviews. Immunology)
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. (Blood)
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cells (Nature Immunology)
Their papers
- Th17 cells express interleukin-10 receptor and are controlled by Foxp3− and Foxp3+ regulatory CD4+ T cells in an interleukin-10 dependent manner (2011) — 603 citations
- Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 (2006) — 758 citations
- Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans (2006) — 1,284 citations
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. (2005) — 1,190 citations